Krzysztof Wrzesinski†a, Maria Chiara Magnone†b, Line Visby Hansenc, Marianne Ehrhorn Krused, Tobias Bergauere, Maria Bobadillab, Marcel Gublerb, Jacques Mizrahib, Kelan Zhangd, Christina M. Andreasenf, Kira Eyð Joensena, Signe Marie Andersena, Jacob Bastholm Olesena, Ove B. Schaffalitzky de Muckadellg and Stephen J. Fey*a
aDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark. E-mail: sjf@bmb.sdu.dk; Fax: +45 6550 2467; Tel: +45 6550 2440
bpRED, Pharma Research and Early Development, DTA CVM, F. Hoffmann-La Roche, Basel, Switzerland. E-mail: maria_chiara.magnone@roche.com; Fax: +41 61 68 79141; Tel: +41 61 20 10500
cScience and Technology, Aarhus, Denmark. E-mail: linevh@orion.au.dk; Tel: +45 7455 2400
dDrugMode ApS, Southern Denmark Research Park, Odense, Denmark. E-mail: kelanzhang@hotmail.com; Fax: +45 6315 7801; Tel: +45 6315 7800
epRED, Pharma Research and Early Development, Translational Research Sciences (TRS), F. Hoffmann-LaRoche, Basel, Switzerland. E-mail: tobias.bergauer@roche.com
fDepartment of Orthopaedics and Traumatology, Odense University Hospital, Odense, Denmark. E-mail: christina.moeller.andreasen@ouh.regionsyddanmark.dk; Tel: +45 5160 5534
gDepartment of Medical Gastroenterology, Odense University Hospital, Odense, Denmark. E-mail: sdm@ouh.regionsyddanmark.dk; Fax: +45 6611 1328; Tel: +45 6541 2750
First published on 16th January 2013
Primary human hepatocytes are widely used as an in vitro system for the assessment of drug metabolism and toxicity. Nevertheless a cell system with higher stability of physiological functions is required for the investigation of drugs’ mode of action, pathway analyses and biomarkers evaluations. We recently discovered that the human hepatocellular carcinoma cell line, HepG2/C3A, cultured as spheroids in a 3D system can recover their main functions after trypsinisation within about 18 days. The objective of this study was to investigate whether the spheroids’ metabolic functions remained stable after this recovery period. Therefore we evaluated physiological capabilities of the spheroids (cell survival, growth rate, glycogenesis, ATP, cholesterol and urea synthesis and drug metabolism) and the expression of key genes related to the main liver pathways in spheroids cultured for an additional 24 days after full recovery (day 18). Here we show that after the recovery period, the 3D spheroid culture can provide a metabolically competent homeostatic cell model which is in equilibrium with its culture environment for more than 3 weeks. Such a stable system could be used for the assessment of the drugs’ mode of action, for biomarkers evaluation and for any systems biology studies which require medium- to long-term stability of metabolic functions.
In a recent study, we compared cells grown in a classical 2D cell culture and 3D spheroid formats in otherwise identical culture conditions. We reported that the 3D spheroid culture systems allow cells to recover from trypsinisation and re-establish their advanced functions (such as cellular organisation, cholesterol and urea synthesis and cytochrome P450 expression) within 15–18 days. During the recovery process, the cells in the spheroids are engaged in re-establishment of their key functions and their growth rate slows down. The cells undergo a clear transition approximately 18 days after culture initiation after which the cell activities stabilise. Before transition the amounts of ATP, urea, cholesterol and adenylate kinase all increase. After the transition, the amounts of adenylate kinase and cholesterol secreted fall while ATP and urea increase (at least up to day 21 at which timepoint that study was ended).4
In this study we investigate the question as to whether the cell functions recovered after the first 21 days in culture are maintained from day 21 to day 42. Few studies have followed the physiological capacity of immortal cells for six weeks post trypsinisation and investigated whether the 3D spheroid system is able to respond to physiological and pharmacological stimulations in a way that reproduces in vivo liver functions.
The parameters that have been investigated in this study were general cell viability (growth rate, ATP synthesis and adenylate kinase release), basal physiological capacity as illustrated by glucose metabolism, urea production, cholesterol synthesis and response to pharmacological treatment (inhibition of cholesterol production by lovastatin). We have also evaluated the expression of key genes involved in the liver functions under evaluation (e.g. glycogen and glucose metabolism, cholesterol synthesis, urea cycle, bile acids synthesis and transport) to confirm the stability of the molecular pathways behind the physiological functions.
All of these assays, without exception, demonstrate that, once the spheroids have passed through the transition (which occurs about 15–18 days after culture initiation), they exhibit a very stable functionality for at least a further 24 days. Thus 3D spheroids cultivated in the microgravity ProtoTissue™ bioreactor provide a biological system ‘at rest’ or in equilibrium where a minimum of background ‘noise’ from extraneous cellular processes is of value. The spheroid system provides a useful tool for drug discovery for understanding compounds’ mode of action and for the evaluation of pharmacodynamics and/or mechanistic biomarkers.
Cell lysates were incubated at 95 °C for 1 h and then cooled in ice. 2 mg unlabeled glycogen and 1 ml 95% ethanol were added to each sample and they were left overnight at −20 °C to precipitate the glycogen. Samples were spun at 12500g for 10 minutes and the supernatant was aspirated. Precipitates were solubilized by shaking in formic acid. 1 ml OptiPhase Hisafe 2 liquid scintillation cocktail was added and samples were mixed thoroughly. The amount of radioactive material in each sample was quantified using a Wallac 1450 microbeta scintillation counter. The glycogen content of the individual samples was related to their total protein content.
In a parallel experiment, the influence of the glucose concentration in the media was investigated. The above procedure was repeated except that the incubation was carried out in DMEM with 5.5, 11.1 or 25 mM glucose containing 1.6, 3.2 or 7.3 μCi ml−1D-[U-14C]-glucose respectively and cultivated for 2.5 h. No additional insulin was added.
Reverse transcription of RNA was accomplished using the SuperScript III First-Strand Synthesis Kit (Invitrogen) according to the manufacturer's protocol with a total RNA input of 100 ng per reaction. cDNA samples were then diluted 1:3 in TE buffer and 14 cycles of pre-amplification were carried out using 2× TaqMan PreAmp Master Mix (Applied Biosystems) and pooled Taqman Assays (Applied Biosystems) at a final concentration of 0.2× per assay. The following thermocycler program was used: 95 °C for 10 min, followed by 14 cycles at 95 °C for 15 s and 60 °C for 4 min. Pre-amplified cDNA products were diluted 1:5 in TE buffer. qPCR was performed using the 96.96 dynamic array (Fluidigm Corporation, CA, USA) following the manufacturer's protocol (Fluidigm Quick Reference Card, PN 68000130, Rev. B). Briefly, for each sample a 5 μl sample mix was prepared with 1× GE Sample Loading Reagent (Fluidigm), 1× Taqman Gene Expression Mastermix (Applied Biosystems) and diluted, pre-amplified cDNA. For the assay mix 1× Assay Loading Reagent (Fluidigm) was mixed with each of the Taqman Assays (final concentration: 10×), respectively. Priming of the Fluidigm array with a control line fluid and mixing of the sample and assay reagents were done with an IFC controller. qPCR was performed using a BioMark Instrument with the following cycling parameters: 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min. Data were collected and analyzed with Real-Time PCR Analysis Software (Fluidigm Corporation, CA, USA).
Cholesterol synthesis was measured by then adding 7 μCi ml−1 [1–14C]-sodium acetate (Perkin Elmer, cat. no.: NEC084H001MC) to triplicate 3D cultures in bioreactors and incubating for 4 h. The cholesterol content of the individual samples was related to their total protein content determined from a small sample of the NaOH spheroid lysate.7
For gene expression normalization was performed using geometric mean expression of housekeeping genes GUSB, H6PD and ALAS1: ΔCq = Cq gene of interest − Cq geomean Housekeepers. The Relative Quantification methodology (ΔCq) was used to calculate expression changes over time relative to day 21.
For the statistical analysis of the effect of glucose concentration and lovastatin treatment, the two-tailed Student's t-test was used. For analysis of variance of cholesterol synthesis at the different time points, one-way analysis of variance (ANOVA) with Tukey error protection was used. For analysis of variance of glycogen synthesis stimulated by insulin at the different time points two-way ANOVA was performed. Analyse-it Method Evaluation Tool version 2.12 by Analyse-it Software, Ltd was used to aid statistical analysis.
Fig. 1 Growth of C3A spheroids during 42 days. (A–D) Photomicrographs of spheroid cultures at 21, 28, 35 and 42 days respectively. The bar in (A) indicates 1 mm. (E) Cell growth in 3D cultures. Spheroids were cultivated in the ProtoTissue™ bioreactor. Duplicate bioreactors were terminated at different times and the protein content of on average 170 spheroids was estimated at each time point for each bioreactor using the relationship between their shadow area and protein content. The growth rate was determined from the incremental increase in the total protein content of the bioreactor. The error bars indicating standard deviation are in some cases smaller than the symbol. |
During the first 21 days the amount of ATP increased. Thereafter the ATP levels stabilised and remained constant (Fig. 2A). The data for adenylate kinase showed that the percentage of dead cells is also essentially constant (Fig. 2B). Both assays thus indicate that the viability of the cultures between day 21 and 42 remains constant, illustrating that the falling growth rate was not due to a reduction in viability.
Fig. 2 Viability of spheroids in long term cultures. (A) The total amount of ATP present in quadruplicate 3D cultures. Data were normalised to mM per day per gram of total cellular protein (gTP). (B) The percentage of dead cells present in quadruplicate 3D cultures, as estimated by adenylate kinase release. Error bars indicate standard deviation and are in some cases smaller than the symbol. |
Fig. 3 Glycogen synthesis in spheroids. Relationship between the glucose concentration in the growth medium and glyconeogenesis in quadruplicate samples of 21 day old spheroids. Error bars indicate standard deviation. |
Fig. 4 Urea and cholesterol production in long term spheroid cultures. The growth media was collected from duplicate ProtoTissue™ bioreactors, clarified by centrifugation and the amount of urea (A) or cholesterol (B) present quantitated at the times shown. Data were normalized to mM or μM per day per gram of total cellular protein (gTP). The data from day 0 to day 21 for both urea and cholesterol were previously presented in ref. 4. Error bars indicate standard deviation and are in some cases smaller than the symbol. |
Gene name | Biological function | Normalized median expression (at day 21) | Expression categorya | Relative normalized expression % (compared to day 21 = 100%) | ||
---|---|---|---|---|---|---|
Day 28 | Day 35 | Day 42 | ||||
a For convenience they have been grouped into three expression groups: high: ΔCq (−16 ≤ x < −6); medium: ΔCq (−6 ≤ x < 6); low: ΔCq (6 ≤ x < 16). | ||||||
SLC2A2 (GLUT2) GS | Glucose import and glycogen synthesis | 1.2 | Medium | 90 | 98 | 95 |
High | 91 | 85 | 80 | |||
FBP1 | Gluconeogenesis | 4.8 | Medium | 81 | 75 | 92 |
G6PC | −2.5 | Medium | 98 | 98 | 98 | |
PCK2 | −0.6 | Medium | 96 | 94 | 97 | |
ARG1 | Urea production | 7.0 | Low | 87 | 93 | 90 |
HMGCR SLCO1B1 (OATP1B1) | Cholesterol biosynthesis | −1.8 | Medium | 96 | 91 | 97 |
Lovastatin transport | −15.9 | High | 91 | 98 | 90 | |
SLCO1A2 | Bile acid import/export and synthesis | −15.9 | High | 95 | 98 | 97 |
CYP7A1 | 6.6 | Low | 88 | 91 | 91 | |
SLC10A1 | 12.0 | Low | 84 | 75 | 63 | |
CYP3A4 | Drug metabolism | 10.2 | Low | 68 | 59 | 61 |
CYP1A1 | Paracetamol detoxification | 5.4 | Medium | 84 | 90 | 77 |
CYP1A2 | 4.6 | Medium | 95 | 89 | 90 | |
ALB | Liver specific genes | −9.3 | High | 95 | 96 | 97 |
F7 | 0.9 | Medium | 94 | 97 | 89 | |
FABP1 | −5.6 | High | 94 | 98 | 89 | |
TF | −7.0 | High | 92 | 94 | 96 |
It is important to note that the steady state rates of synthesis for both urea and cholesterol were significantly above the synthesis rates seen during the first few days of culture.
Fig. 5 Effect of insulin on glycogen synthesis in long term spheroid cultures. Quadruplicate spheroid cultures of different ages (A: 21 days; B: 28 days; C: 35 days and D: 42 days) were grown in the presence of either 5.5 or 11 mM glucose and treated or mock treated with 100 nM insulin. Results have been normalised to the level of glycogen synthesis in the control mock-treated spheroids grown in 5.5 mM glucose. Error bars indicate standard deviation. |
A comparison of the increase in glycogen synthesis comparing spheroids grown in 11.1 compared to 5.5 mM glucose showed that the difference was statistically significant (Student's t-test) for the 21, 35 and 42 day cultures (p = 0.03, 0.01 and 0.01 respectively, indicated in the figure by the * over the black bars) but not at 28 days (p = 0.12).
Spheroid age (days) | Treatment (h) | Lovastatin | Student's t-test | |||
---|---|---|---|---|---|---|
0 μM | 10 μM | |||||
CPM | SD | CPM | SD | p | ||
21 | 4.5 | 38281 | 3068 | 462 | 113 | 0.002 |
42 | 4.5 | 37557 | 7646 | 7452 | 11939 | 0.020 |
Spheroid age (days) | Treatment (h) | Lovastatin | Student's t-test | |||
---|---|---|---|---|---|---|
0 μM | 1 μM | |||||
CPM | SD | CPM | SD | p | ||
35 | 22 | 56077 | 16810 | 110636 | 19185 | 0.020 |
The main difference between cells cultured using the classical culture conditions (in the bottom of microtitre plates, flasks etc., i.e. ‘flat or 2D culture’ conditions) and spheroids (true 3D culture) is the fact that the cells can grow undisturbed in a 3D environment (i.e. without suffering damage by trypsinisation), receive an active supply of nutrients as the growth media ‘flows past’ and they can develop tight interactions with other cells and recover functionality typical of normal hepatocytes. This allows the cells to develop several ultrastructural and physiological features that do not normally have time to develop when the same cells are grown in otherwise the same conditions using classical cell and tissue culture procedures. These features include tight junctions, microvillae, bile canaliculae-like tubules, glycogen granules, urea and cholesterol secretion. Judged by their morphologic appearance, growth rate, the production of ATP, adenylate kinase, cholesterol and urea, the spheroids need at least 18 days to recover.4 These observations would be fully compatible with the recent report that sandwich-cultured rat hepatocytes need 6 days to establish cell polarity and bile canaliculi8 because in the spheroid system presented here, the hepatocytes first have to synthesise their own extracellular matrix (which is otherwise provided in the sandwich-culture models) before they do the same.
The outstanding question examined in this report concerns the functional stability of hepatocyte spheroids after the recovery process and their reactivity to physiological and pharmacological stimulations. In particular, we have investigated basal 3D spheroid activities (cell growth and expression of liver-specific genes) and four of the core functions performed by the liver: glycogen synthesis and response to insulin stimulation; urea production, cholesterol production and its inhibition by lovastatin. In addition, we have measured the expression of some key genes related to hepatocyte specific functions. These results have shown that the features developed by the spheroids are stable for at least 21 days once they have been established (i.e. spheroids are metabolically stable from day 21 to 42 in culture). This period of stability is probably much longer because spheroids have been cultivated in our laboratories without trypsinisation for up to 302 days (at which time point the culture still looked perfectly healthy).
In addition, gene expression analysis showed that the cells in the 3D spheroids express a wide set of liver-specific proteins, thus indicating that they are in a fully differentiated state.
Finally, 3D spheroids also express genes of key pathways related to liver functions, which make them amenable for exploratory investigations such as biomarker discovery and drug mode of action studies.
In addition to the reactivity of the system to insulin in terms of glycogen synthesis, we evaluated the expression of key genes in the gluconeogenesis pathway, such as glucose 6-phosphatase, fructose biphosphatase and phosphoenolpyruvate carboxykinase, and we observed a similar level of expression from day 21 to 42, indicating the maintenance of gluconeogenic pathway over 3 weeks (Table 1).
Overall, our data indicate that the spheroids maintain their functionality in glucose and glycogen metabolism from day 21 to 42. Our data are partially in contrast with a study by Dabos et al., where they found significant changes in a number of parameters (including glucose, lactate, pyruvate, amino acids, urea and ethanol production) during a 21 day spheroid culture of primary porcine hepatocytes. Interestingly they described a progressive switch in the metabolism from anaerobic (and active gluconeogenesis) to aerobic (with restricted gluconeogenesis) during days 7–10.12 The observed differences may reflect intrinsic differences in growth potential between the decline of primary cells and immortal cell lines in culture.
One key feature of hepatocytes cell lines grown in 2D systems, such as HepG2 and HepG2/C3A cells, is that they have lost the capability to detoxify ammonia, in that they have a non-functional urea cycle (HepG2 cells do not express Arg115), and the urea that they do produce (0.160 mM per day per gTP) is produced via Arg2 (HepG2/C3A cells13,16). The level of urea production of HepG2/C3A cells was shown to be sensitive to glucose levels, being highest (1.7 mM per day per gTP) in a glucose-free media.14 In our 3D spheroid system, urea production between day 21 and 42 is in the range of 1.6 ± 0.35 mM per day per gTP. This system stably expresses Arg1 at low levels, thus suggesting that ammonia detoxification may be possible.
Cholesterol synthesis was not stable and reached a peak at around day 10 in Hep2 cells cultured for 21 days on alginate spheroids.20 In our spheroid system, the cholesterol levels appear constant between day 21 and day 42. Consistently, HMG-CoAR gene expression levels do not change throughout the three week period.
Out of the 12 transporters (SLCO1A2, SLCO2B1, SLCO1B1, SLCO3A1, SLCO4A1, SLCO1B3, SLC22A7, SLC22A8, SLC22A1, SLC10A1, SLC15A1, and SLC15A2) investigated in HepG2 cells, Libra found 11 expressed. Of these, the gene expression of SLCO1B1, SLCO3A1, and SLCO1B3 was greatly repressed, while the expression of SLCO2B1, SLC22A7, and SLC22A8 was either maintained or increased in HepG2 in comparison to their expression in human liver.21 Currently it is not clear whether the high expression of SLCO1A2 and SLCO1B1 seen here is a specific difference between the HepG2 cells and HepG2/C3A or whether the spheroid culture has induced their expression. Several other transporters have also been shown to be expressed and active in HepG2 and HepG2/C3A cell lines. These include P-gp (MDR1 or ATPB1), and MRP2 (cMOAT),22–24 and several amino acid transporters (SLC7A11, SLC1A4, and SLC3A2).25
Interestingly the increasing amounts of cholesterol seen following the recovery period would be expected to induce an increase in SCL10A1 and SCL22A1 (but not of SCLO1A2 (OATP1A2) or CYP3A4).26 This would be a logical preparation for bile synthesis and secretion. The results observed here: low expression of SCL10A1, CYP3A4 and high expression of SCLO1A2 therefore present an incomplete picture.
It is interesting to note that the same HepG2/C3A cells, which in 2D systems show several limitations (e.g. low cholesterol production, no urea cycle, reduced cytochromes function), recover the functionality typical of human liver in the 3D spheroid system.
Finally, a general limitation shared between our 3D spheroid system and other 3D and 2D systems that are composed of primary hepatocytes or immortalized cell lines is that they do not capture the interactions with other relevant liver cell types, such as Kupffer cells, stellate cells and endothelial cells, which are functional partners of hepatocytes in the liver.
Nevertheless, the 3D spheroid system shows a number of advantages that largely outweighs the limitations. First of all, this culturing system allows HepG2/C3A cells to recover some key functions that are typical of the liver and that are lost in 2D systems. Whether this is due to the resuming of the differentiation program or to the simple fact that cells can recover undisturbed for a longer time is not clear at this point in time. Certainly, using HepG2/C3A cells provides a practically unlimited amount of identical starting material, which ensures a greater biological homogeneity as compared to primary hepatocytes.
In addition, the 3D spheroid system allows the cells to be functionally stable for several weeks (in a pilot study spheroids were cultured for up to 302 days), thus enabling long-term studies.
The low biological variability and the long-term stability make this system particularly useful for the investigations of the compounds mode of action, toxicology and for biomarker discovery. Further developments (e.g. deep focus confocal microscopy) and novel handling procedures will pave the way for the introduction of 3D culture into the mainstream of biology.
Footnote |
† These authors equally contributed to the study. |
This journal is © The Royal Society of Chemistry 2013 |